Patents by Inventor Rahela Gasparac

Rahela Gasparac has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF ADMINISTERING A 5,5-FUSED HETEROARYLENE HEPATITIS C VIRUS INHIBITOR FOR TREATING OF PREVENTING HEPATITIS C VIRUS INFECTION
    Publication number: 20150224085
    Abstract: Provided herein are methods of administering a 5,5-fused heteroarylene hepatitis C virus inhibitor compound or an isotopic variant thereof, or a pharmaceutically acceptable salt or solvate thereof; for treating or preventing hepatitis C virus infection in a subject.
    Type: Application
    Filed: August 29, 2013
    Publication date: August 13, 2015
    Applicant: Indenix Pharmaceuticals, Inc
    Inventors: Rahela Gasparac, Benjamin Mayes, Adel Moussa, Keith Piet-Ropaolo, John Sullivan-Bolyai, Xiao-Jian Zhou
  • Co-crystals and pharmaceutical formulations comprising the same
    Patent number: 8541025
    Abstract: An immediate release formulation of an active ingredient.
    Type: Grant
    Filed: February 24, 2011
    Date of Patent: September 24, 2013
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Eleni Dokou, Rahela Gasparac, Dragutin Knezic, Billie J. Kline, Valdas Jurkauskas
  • CO-CRYSTALS AND PHARMACEUTICAL FORMULATIONS COMPRISING THE SAME
    Publication number: 20110236478
    Abstract: An immediate release formulation of an active ingredient.
    Type: Application
    Filed: February 24, 2011
    Publication date: September 29, 2011
    Applicant: VERTEX PHARMACEUTICALS INCORPORATED
    Inventors: Eleni Dokou, Rahela Gasparac, Dragutin Knezic, Billie J. Kline, Valdas Jurkauskas
  • Electrocatalytic nucleic acid hybridization detection
    Patent number: 7741033
    Abstract: The detection of specific nucleic acid sequences using electrochemical readout would permit the rapid and inexpensive detection and identification of bacterial pathogens and the analysis of human genes. A new assay developed for this purpose is described that harnesses an electrocatalytic process to monitor nucleic acid hybridization. Furthermore, the new assay when used on nanoscale electrodes, provides ultrasensitive detection of nucleic acids.
    Type: Grant
    Filed: August 6, 2004
    Date of Patent: June 22, 2010
    Assignee: Trustees of Boston College
    Inventors: Shana Kelley, Rahela Gasparac, Melissa Lapierre-Devlin, Bradford Taft
  • Electrocatalytic nucleic acid hybridization detection
    Publication number: 20050084881
    Abstract: The detection of specific nucleic acid sequences using electrochemical readout would permit the rapid and inexpensive detection and identification of bacterial pathogens and the analysis of human genes. A new assay developed for this purpose is described that harnesses an electrocatalytic process to monitor nucleic acid hybridization. Furthermore, the new assay when used on nanoscale electrodes, provides ultrasensitive detection of nucleic acids.
    Type: Application
    Filed: August 6, 2004
    Publication date: April 21, 2005
    Inventors: Shana Kelley, Rahela Gasparac, Melissa Lapierre-Devlin, Bradford Taft